Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx Inc COMMON STOCK | 6,720,803 | 6,720,803 | 0 | $438.20M | $771.68M | 36.44% | +$333.49M |
| Arcus Biosciences, Inc.(RCUS) | 31,424,760 | 31,424,760 | 0 | $748.85M | $678.77M | 32.05% | -$70.08M |
| Lakefront Biotherapeutics NVADR(LKFT) | 16,707,477 | 16,707,477 | 0 | $550.62M | $501.22M | 23.67% | -$49.39M |
| Assembly Biosciences Inc | 4,505,391 | 4,505,391 | 0 | $153.23M | $125.02M | 5.90% | -$28.20M |
| Kyverna Therapeutics, Inc.(KYTX) | 4,126,119 | 4,126,119 | 0 | $38.79M | $35.61M | 1.68% | -$3.18M |
| Xilio Therapeutics, Inc.(XLO) | 9,105,451 | 650,389 | -8,455,062 | $5.83M | $5.47M | 0.26% | -$359.5K |